Template:ST elevation myocardial infarction: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 190: | Line 190: | ||
::[[Door-to-balloon|The importance of reducing Door-to-Balloon times]] | ::[[Door-to-balloon|The importance of reducing Door-to-Balloon times]] | ||
::[[ST elevation myocardial infarction primary percutaneous coronary intervention|Primary PCI]] | ::[[ST elevation myocardial infarction primary percutaneous coronary intervention|Primary PCI]] | ||
::Adjunctive and Rescue PCI | ::[[ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration|Adjunctive and Rescue PCI]] | ||
::Rescue PCI | ::[[ST elevation myocardial infarction rescue percutaneous coronary intervention|Rescue PCI]] | ||
::Facilitated PCI | ::[[ST elevation myocardial infarction facilitated percutaneous coronary intervention|Facilitated PCI]] | ||
::Adjunctive PCI | ::[[ST elevation myocardial infarction adjunctive percutaneous coronary intervention|Adjunctive PCI]] | ||
::CABG | ::[[ST elevation myocardial infarction coronary artery bypass grafting|CABG]] | ||
::Management of Patients Who Were Not Reperfused | ::[[ST elevation myocardial infarction management of patients who were not reperfused|Management of Patients Who Were Not Reperfused]] | ||
::Assessing Success of Reperfusion | ::[[ST elevation myocardial infarction assessing success of reperfusion|Assessing Success of Reperfusion]] | ||
:Antithrombin Therapy | :Antithrombin Therapy | ||
::Antithrombin therapy | ::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy|Antithrombin therapy]] | ||
::Unfractionated heparin | ::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Unfractionated Heparin|Unfractionated heparin]] | ||
::Low Molecular Weight Heparinoid Therapy | ::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Enoxaparin|Low Molecular Weight Heparinoid Therapy]] | ||
::Direct Thrombin Inhibitor Therapy | ::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Bivalirudin|Direct Thrombin Inhibitor Therapy]] | ||
::Factor Xa Inhibition | ::[[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Fondaparinux|Factor Xa Inhibition]] | ||
::DVT prophylaxis | ::[[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|DVT prophylaxis]] | ||
::Long term anticoagulation | ::[[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|Long term anticoagulation]] | ||
:Antiplatelet Agents | :Antiplatelet Agents | ||
::Aspirin | ::Aspirin |
Revision as of 18:23, 8 May 2014
ST elevation myocardial infarction Microchapters |
Differentiating ST elevation myocardial infarction from other Diseases |
---|
Diagnosis |
Treatment |
|
Long-Term Medical Therapy and Secondary Prevention
|
Case Studies |
ST elevation myocardial infarction On the Web |
Directions to Hospitals Treating ST elevation myocardial infarction |
Risk calculators and risk factors for ST elevation myocardial infarction |